Literature DB >> 2928882

Phenytoin auto-induction? Case reports.

R Miller1, P L Bill, J Du Toit.   

Abstract

Auto-induction of phenytoin metabolism is considered by many to be insignificant. Two cases, in which elimination of phenytoin apparently increased with continuous use, are presented. The first patient showed an increase in elimination capacity (Vmax) from 511 mg/d to 613 mg/d over a period of 5 months. The second patient showed an increase in Vmax from 512 mg/d to 570 mg/d over a period of 1 year. In neither case was compliance in question. The recognition that therapeutic failure may be due to enzyme induction could obviate expensive diagnostic procedures as well as narrow down the therapeutic alternatives.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2928882

Source DB:  PubMed          Journal:  S Afr Med J


  2 in total

1.  Assessment of inter-individual variability in predicted phenytoin clearance.

Authors:  Thomas M Polasek; Sebastian Polak; Matthew P Doogue; Amin Rostami-Hodjegan; John O Miners
Journal:  Eur J Clin Pharmacol       Date:  2009-12       Impact factor: 2.953

2.  CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose.

Authors:  Amarjit S Chaudhry; Thomas J Urban; Jatinder K Lamba; Angela K Birnbaum; Rory P Remmel; Murali Subramanian; Stephen Strom; Joyce H You; Dalia Kasperaviciute; Claudia B Catarino; Rodney A Radtke; Sanjay M Sisodiya; David B Goldstein; Erin G Schuetz
Journal:  J Pharmacol Exp Ther       Date:  2009-10-23       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.